AMICUS THERAPEUTICS, INC. — Director's Dealing 2025

Feb 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2025-02-19

Reporting Person: Campbell Bradley L (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-19	Common Stock	M	400	$9.03	Acquired	1151057	Direct
2025-02-19	Common Stock	S	400	$10	Disposed	1150657	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-19	Stock Options (right to buy)	$9.03	M	400	Disposed	2026-01-04	Common Stock (400)	Direct

Footnotes

F1: All of the options were fully vested and exercisable as of the transaction date.